Select Medical (NYSE:SEM) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research report report published on Wednesday.

Several other research analysts have also recently commented on SEM. Bank of America initiated coverage on shares of Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. Royal Bank of Canada raised their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Benchmark reiterated a “buy” rating and set a $48.00 price target on shares of Select Medical in a research report on Friday, November 1st. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $40.75.

Select Medical Price Performance

Shares of NYSE:SEM opened at $37.45 on Wednesday. The company has a market cap of $4.85 billion, a PE ratio of 17.50, a P/E/G ratio of 1.99 and a beta of 1.42. Select Medical has a fifty-two week low of $22.26 and a fifty-two week high of $40.98. The firm has a 50-day simple moving average of $34.81 and a 200 day simple moving average of $34.73. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the prior year, the firm earned $0.46 EPS. The business’s quarterly revenue was up 5.7% on a year-over-year basis. On average, sell-side analysts anticipate that Select Medical will post 2.16 EPS for the current year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be issued a dividend of $0.125 per share. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 1.34%. Select Medical’s payout ratio is 23.36%.

Institutional Trading of Select Medical

Hedge funds and other institutional investors have recently modified their holdings of the company. Price T Rowe Associates Inc. MD grew its holdings in Select Medical by 0.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,202,219 shares of the health services provider’s stock worth $518,647,000 after acquiring an additional 90,604 shares during the period. Vanguard Group Inc. boosted its position in shares of Select Medical by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after purchasing an additional 650,093 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Select Medical by 2.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after purchasing an additional 95,578 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after purchasing an additional 46,880 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after buying an additional 147,032 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.